Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD) [Phase 4]
A Phase 4 clinical trial evaluating the cardiovascular effects of agomelatine versus escitalopram in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults [Phase 2]
A Phase 2 randomized, placebo-controlled trial evaluated the efficacy and safety of 5 mg and 10 mg vortioxetine (Lu AA21004) versus placebo,…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD) [Phase 2]
Phase 2 open-label extension study assessing tolerability of combining BCI-024 with BCI-049 in adults with major depressive disorder; result…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults [Phase 2]
This update reports results from an open-label safety extension of vortioxetine (5 and 10 mg) for long-term treatment of adults with major d…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Culturally Adapted Cognitive Behavioral Therapy for Prevention of Self Harm [NA]
This clinical trial update reports on a culturally adapted cognitive-behavioral therapy to prevent self-harm in individuals with depression …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-12-17FDA Approved: DULOXETINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for a generic duloxetine product. The approval makes low-cost generic duloxetine av…
-
FDA approval · 2013-12-16FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline), enabling a new generic versi…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Comparison of Two tDCS Protocols for the Treatment of Major Depressive Disorder [NA]
A completed clinical trial comparing two transcranial direct current stimulation (tDCS) protocols for major depressive disorder has been rep…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients
Clinical trial update evaluating antidepressant monotherapy on depressive and anxiety symptoms in Chinese patients.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial results show efficacy and safety data for vortioxetine in adults with major depressive disorder (Takeda-sponsored; co…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial update reporting on the safety and tolerability of vortioxetine (Lu AA21004) in adults with major depressive disorder…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression [NA]
This clinical trial evaluated repetitive transcranial magnetic stimulation (rTMS) as an adjuvant treatment for major depressive disorder. Th…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Mental Health Symptoms and Intimate Partner Violence
A completed clinical trial update describing a study on mental health symptoms in individuals affected by intimate partner violence, with fo…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Acupuncture for Persistent Insomnia Associated With Major Depressive Disorder [NA]
The clinical trial update indicates that the acupuncture study for persistent insomnia associated with major depressive disorder has complet…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Promotion of Self-help Strategies for Depression [Phase 1, Phase 2]
The clinical trial evaluating self-help strategies for depression completed Phases 1 and 2, sponsored by Orygen.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approves duloxetine hydrochloride generic by Marksans Pharma Limited under an Original ANDA (ANDA 090723).
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for a generic duloxetine product (DULOXETINE). This approval allows the mar…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic duloxetine under an Original Application, authorizing a generic version of the reference duloxet…
-
FDA approval · 2013-12-10FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to authorize an extended-release formulation of Pristiq (desvenlafaxine succinate). This expands…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Developing a Self-Management Program for People With Depression and Chronic Medical Illness [NA]
The clinical trial investigating a self-management program for people with depression (and chronic medical illness) has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings [NA]
Completed clinical trial investigating treatment preferences among low-income Latino patients with depression in primary care settings.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Culturally Sensitive Collaborative Treatment for Depressed Chinese Americans [NA]
A clinical trial conducted by Massachusetts General Hospital examining a culturally sensitive collaborative treatment approach for depressio…
-
CLINICAL_TRIALS research · 2013-12-09Clinical Trial Update: A Novel Person-Centered Treatment Component for Substance Use Treatment [NA]
A completed clinical trial update reports on a novel person-centered treatment component for substance use treatment. The study also involve…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Group Psychotherapy for People With HIV [NA]
A completed clinical trial evaluating group psychotherapy for people with HIV, focusing on comorbid depression.